Navigation Links
Boston Scientific Announces Results for Third Quarter Ended September 30, 2009
Date:10/19/2009

------------- ------------- in millions, 2009 2008 2009 2008 except per share data ---- ---- ---- ---- ---------------------- Net sales $2,025 $1,978 $6,109 $6,048 Cost of products sold 629 655 1,867 1,839 --- --- ----- ----- Gross profit 1,396 1,323 4,242 4,209 Operating expenses: Selling, general and administrative expenses 665 610 1,987 1,925 Research and development expenses 258 252 778 749 Royalty expense 51 51 149 144 Loss on program termination 16 Amortization expense 126 131 381 410 Intangible asset impairment charges 155 10 155 Purchased research and development (8) 17 21 Acquisition-related milestone (250) (250) Gain on divestitures (250) Restructuring charges 9 20 44 59 Litigation-related net (credits) charges (58) 334 229 334 --- --- --- --- 1,051 1,295 3,611 3,297 ----- ----- ----- ----- Operating income 345 28 631 912 Other Income (expense): Interest expense (91)
'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine technology :

1. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
2. Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents
3. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
4. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
5. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
6. SPIRIT IV Results Reaffirm Strong Performance of Boston Scientific PROMUS(R) and TAXUS(R) Express(R) Stents
7. Boston Scientific Announces Schedule for European Society of Cardiology Congress
8. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
9. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
10. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
11. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Reportlinker.com announces that a new ... North America Laparoscopes Market Outlook to ... North America Laparoscopes Market Outlook to 2020 ... Laparoscopes Market Outlook to 2020", provides key market ... report provides value, in millions of US dollars, ...
(Date:8/28/2014)... , Aug. 28, 2014 Takeda Pharmaceutical ... post-marketing commitment and submissions of data from a ... the United States (U.S.) Food ... (EMA) and the Japanese Ministry of Health, Labour, ... Medical Devices Agency (PMDA) for pioglitazone containing medicines, ...
(Date:8/28/2014)... 28, 2014 Levi & Korsinsky announces that ... United States District Court for the District of ... purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: ... 2014. For more information, click here: ... the Class Period the Company violated federal securities laws ...
Breaking Medicine Technology:North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2
... Polar ( www.polarusa.com ), the leader in ... it has been named a " Best Company to Work ... York State Society for Human Resource Management, Inc., the Business ... 22 in the under 250 employees group. The award honors ...
... oncology electronic medical record (EMR) – the first ... under the HITECH Act – has propelled Elekta to ... hematology EMR vendors in the annual Black Book Rankings ... "comprehensive ambulatory EMR vendor" were: electronic health records and ...
Cached Medicine Technology:Polar USA Named a Best Company to Work for in New York for Second Straight Year 2Elekta's MOSAIQ Far Ahead of Contenders in Black Book Rankings User Survey of EMR Vendors 2Elekta's MOSAIQ Far Ahead of Contenders in Black Book Rankings User Survey of EMR Vendors 3
(Date:8/29/2014)... for a burn as a child experience higher than usual ... at the University of Adelaide . , A 30-year ... the University,s Centre for Traumatic Stress Studies. They found ... mental illness and 30% suffered depression at some stage in ... Burns , also found that long-term depression ...
(Date:8/29/2014)... New ESC registries are being launched on cardiac ... comes as the long-term phase of the cardiomyopathy ... failure patients conducted in collaboration with the Organisation ... outcomes evaluation. , The registries are all part ... Professor Roberto Ferrari, Chairperson of EORP, said: "The ...
(Date:8/29/2014)... August 29, 2014 Glendale Botox ... promotion on Botox throughout the month of September. This special ... of two syringes of Juvederm. Patients can take advantage of ... skin. The Glendale Botox experts will work with patients to ... , What is Botox? , Botox is a ...
(Date:8/29/2014)... News) -- The way that parents respond to their ... new study suggests. Over six months, researchers observed ... free play. The sessions were 30 minutes long and ... old at the start of the study. When ... began to form complex sounds. The babies whose parents ...
(Date:8/29/2014)... Los Angeles (PRWEB) August 29, 2014 ... Talk Radio Today at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , ... plus years of money, marital bliss, prodding, laughing ... out of the house this week. Relief ... sense of “now what.” Dr. Carol ...
Breaking Medicine News(10 mins):Health News:Intervention needed for survivors of childhood burns 2Health News:New ESC registries launched on cardiac oncology and ACS 2Health News:New ESC registries launched on cardiac oncology and ACS 3Health News:New ESC registries launched on cardiac oncology and ACS 4Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News:Encouraging Your Baby's Babbling May Speed Language Development 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3
... in the United States will contract a sexually transmitted ... and Prevention. Experts believe a major contributing factor is ... and routinely. Now a new study provides some insight ... among teenagers. , Researchers from the Bradley ...
... Professional Postgraduate Services® (PPS®), renowned for its award-winning healthcare ... RSV and pediatric influenza, Preventing and Managing RSV Disease ... on PediatricRespiratory.org. , ... ...
... company, is thrilled to be included in Inc.,s 27th ... in the country. As the fastest growing company in ... to other healthcare staffing firms making the list it ... traveling healthcare staffing companies. It is the only company ...
... Universal,Health Services, Inc. (NYSE: UHS ) ... to sell Central Montgomery Medical Center, a 125 ... Abington Memorial,Hospital. The sale is subject to customary ... later this fall., UHS also announced that ...
... PITTSBURGH, Sept. 8 Mylan Inc. (NYSE: ... to market and other,conditions, $400 million principal amount ... offering to qualified institutional buyers pursuant,to Rule 144A ... (the "Securities,Act"). Mylan also expects to grant the ...
... spasms are a severe and potentially devastating epilepsy condition ... study appearing in Epilepsia, researchers have found ... diet more traditionally used for intractable childhood epilepsy, is ... The study is the first description of the ketogenic ...
Cached Medicine News:Health News:Teens' failure to use condoms linked to partner disapproval, fear of less sexual pleasure 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 2Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 3Health News:PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza 4Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 2Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 3Health News:Medical Solutions Ranks No. 472 in the 2008 Inc. 500 with Three-Year Sales Growth of 667.8% 4Health News:Universal Health Services, Inc. Announces Sale of Acute Care Hospital and Addition of Two Behavioral Health Hospitals 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 2Health News:Mylan to Offer $400 Million in Cash Convertible Notes 3Health News:Diet may eliminate spasms for infants with epilepsy 2
The ZEPHIR Anterior Cervical Plate System is the lowest profile plate clinically available....
... The Philips Mx8000 IDT six-slice imaging ... incorporating leading technological innovations to maximize ... influencing departmental efficiency to delivering optimal ... the platform for multislice CT today ...
... Sharing the same proprietary Quantum detector technology ... a combination of speed and resolution not available ... to fit your clinical and budgetary needs, the ... a dedicated upgrade path to 16 slice productivity., ...
... TLIF Instruments are designed to facilitate disc ... bone graft during interbody fusion. The TLIF ... easy use during TLIF, for which they ... be used very effectively in PLIF and ...
Medicine Products: